Literature DB >> 9207725

Bevel-down superior to bevel-up in intradermal skin testing.

A Howard1, P Mercer, H C Nataraj, B C Kang.   

Abstract

BACKGROUND: Intradermal skin testing is one of the most widely used procedures in the diagnosis of hypersensitivity diseases in vivo. It is critical to perform the test accurately and expediently. Yet, there are few articles describing its detailed technique or proficiency available.
OBJECTIVES: To identify the better method for intradermal testing between the bevel-up and bevel-down techniques.
METHODS: Three inexperienced testers performed intradermal injections using both methods. Four sets of paired trails each consisting of ten injections were applied randomly, alternating between the same volunteer subject's contralateral arms. Duration to complete ten injections was measured. Numbers of injection sites that bled, that squirted into the air, and failed to form a bleb were counted. The overall comfort level was determined.
RESULTS: The time to complete the injections by bevel-up and by bevel-down methods were 165.5 +/- 31.3 and 152.5 +/- 27.4 seconds, respectively (P < .015). The number of injection sites that bled was higher in the bevel-up method, particularily on trial one (P < .001). Completion rate of successful bleb formation in bevel-down was 27.3 as compared with 23.3 in bevel-up method (P = .013). The comfort level was higher with the bevel-down than the bevel-up method (P = .0001).
CONCLUSION: The bevel-down method of intradermal testing is superior to the bevel-up method.

Entities:  

Mesh:

Year:  1997        PMID: 9207725     DOI: 10.1016/s1081-1206(10)63222-x

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  DNA vaccination in the skin using microneedles improves protection against influenza.

Authors:  Jae-Min Song; Yeu-Chun Kim; Eunju O; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

2.  Stability of influenza vaccine coated onto microneedles.

Authors:  Hyo-Jick Choi; Dae-Goon Yoo; Brian J Bondy; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Biomaterials       Date:  2012-02-21       Impact factor: 12.479

3.  Infusion pressure and pain during microneedle injection into skin of human subjects.

Authors:  Jyoti Gupta; Sohyun S Park; Brian Bondy; Eric I Felner; Mark R Prausnitz
Journal:  Biomaterials       Date:  2011-06-17       Impact factor: 12.479

4.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

5.  Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.

Authors:  Qiyun Zhu; Vladimir G Zarnitsyn; Ling Ye; Zhiyuan Wen; Yulong Gao; Lei Pan; Ioanna Skountzou; Harvinder S Gill; Mark R Prausnitz; Chinglai Yang; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

Review 6.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Mantoux test and its interpretation.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian Dermatol Online J       Date:  2012-01

8.  Transdermal influenza immunization with vaccine-coated microneedle arrays.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Sean P Sullivan; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.